These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4135108)

  • 1. Biochemical aspects of drug combinations.
    Brockman RW
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
    Bono VH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 6. Guide to the use of cancer chemotherapeutic agents.
    Bergevin PR; Tormey DC; Blom J
    Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 8. [6-Thioguanine in the chemotherapy of leukemias].
    Zidermane AA
    Vopr Onkol; 1979; 25(1):74-83. PubMed ID: 284664
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer chemotherapy. II.
    Greenwald ES
    N Y State J Med; 1972 Nov; 72(21):2641-54. PubMed ID: 4117677
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination cancer therapy: Presidential address.
    Frei E
    Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
    [No Abstract]   [Full Text] [Related]  

  • 12. Historical development and future promise of the nitrosoureas as anticancer agents.
    Schabel FM
    Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035
    [No Abstract]   [Full Text] [Related]  

  • 13. An outline of cancer chemotherapy.
    Connors TA
    Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
    [No Abstract]   [Full Text] [Related]  

  • 14. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of anticancer drugs.
    Chabner BA; Myers CE; Oliverio VT
    Semin Oncol; 1977 Jun; 4(2):165-91. PubMed ID: 69319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research results and prospects in the field of experimental leukemia chemotherapy].
    Kozinets GI; Khomchenovskiĭ EI; Reshchikov VP; Khanykova OK; Egorov LV
    Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):3-7. PubMed ID: 368760
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy for spontaneous AKR lymphoma.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Cheeks JB
    Cancer Chemother Rep 2; 1974 Mar; 4(1):53-72. PubMed ID: 4499910
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-kill kinetics of several S-phase-specific drugs.
    Bhuyan BK; Fraser TJ; Gray LG; Kuentzel SL; Neil GL
    Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241
    [No Abstract]   [Full Text] [Related]  

  • 19. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
    LePage GA; White SC
    Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL; Homan ER
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.